Cyclopamine

5 mg

Cat. No.: 29-O52

$199.00

Cyclopamine is a small molecule inhibitor of the sonic hedgehog pathway (Hh) by binding to the heptahelical bundle of Smoothened. It inhibits the growth of medulloblastoma cells. Hedgehog signaling is involved in embryogenesis as well as cancer progression. It is a steroid alkaloid  and originally identified as a teratogenic agent.

 

Details

TECHNICAL INFORMATION

Other Names: 11-deoxojervine (2’R,3S,3’R,3’aS,6’S,6aS,6bS,7’aR,11aS,11bR)-1,2,3,3’a,4,4′,5′; octadecahydro-3′,6′,10,11b-tetramethyl-spiro[9H-benzo[a]fluorene-9,2′(3’H)-furo[3,2-b]pyridin]-3-ol

Chemical Formula:  C27H41NO2

CAS Number: 4449-51-8

Molecular Weight: 411.62

Purity:  >99%

Appearance: Off white solid

Solubility: DMSO

 

STORAGE AND HANDLING

Storage: Store at 4°C and protected from light. Following reconstitution, store  aliquots at -20°C. 

Stability: Stock solutions stable at -20°C for up to 2 years.

Shipping Conditions: Shipped at room temperature.

 

PRODUCT USE

Soluble in DMSO. For a 10 mM concentrated stock solution, reconstitute the compound by adding 486 μl of DMSO to the entire contents of the vial. Note: for most cells, the maximum tolerance to DMSO is <0.5%.

 

References

Chen et al. (2002). Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev. 16(21):2743-8.

Kumar et al. (2008). Targeted inhibition of hedgehog signaling by cyclopamine prodrugs for advanced prostate cancer. Bioorg Med Chem. 16(6):2764-8.

Bar et al. (2007). Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells. 25(10):2524-33.

Tech Docs

Product Specifications

MSDS